Filed in archive
Diagnostics
by Gloria Gamat on October 29, 2006

Characterized by chronic inflammation in the joints, RA is an autoimmune disease by which patients can experience periodic flare-ups that can lead to irreversible joint destruction, if misdiagnosed or left untreated (i).
The EliA™ CCP Assay utilizes a small sample of blood drawn from a patient. The sample is then sent to a lab and analyzed for CCP levels through a CLIA-moderate complexity test, which is available on the ImmunoCAP® 100 and 250, two fully automated systems for autoimmune and allergy testing.
Now, EliAâ„¢ CCP has been cleared by the USFDA for marketing, providing healthcare providers with a more accurate tool in the diagnosis of RA at an early stage in the disease compared to older testing methods.
Find more details from the press release.
(i) Vallbracht I, Rieber J, Oppermann M, et al. Diagnostic and clinical value of anti cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis. 2004; 63:1079-1084.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/40816
Mr Wong
Vote for EliAâ„¢ CCP: New Diagnostic Test that Detects Rheumatoid Arthritis (RA) in Early Stages, Received USFDA Clearance:
|
Rating: 7.25 out of 4 vote(s) cast.
|
Response from:
Gloria
(11/01/06 9:27pm)
that's really great, thanks for the additional information
Response from:
fourmaux
(01/21/10 7:45am)
Bonjour, pourrais obtenir les FDS de Elia CCP, diluant, IgG conjugué et contrôle et calibrateur, Elia JO1, Elia SCL, Elia SM, Elia SSA/RO, Elia SSB/LA, Elia symphony, Elia transglutaminase IgA et Elia U1RNP
merci
merci
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









